Current Status of Immunotherapy for Lung Cancer and Future Perspectives
Ho Cheol Kim, Chang-Min Choi
Tuberc Respir Dis. 2020;83(1):14-19.   Published online 2019 Aug 31     DOI: https://doi.org/10.4046/trd.2019.0039
Citations to this article as recorded by Crossref logo
Characteristics of the Immune Cell Infiltration Landscape in Gastric Cancer to Assistant Immunotherapy
Chenlu Li, Jingjing Pan, Yinyan Jiang, Yan Yu, Zhenlin Jin, Xupeng Chen
Frontiers in Genetics.2022;[Epub]     CrossRef
NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target
Hongbo Huang, Qingwang Hua, Luca Falzone
International Journal of Genomics.2022; 2022: 1.     CrossRef
Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer
Masaya Yotsukura, Kazuo Nakagawa, Kenji Suzuki, Kazuya Takamochi, Hiroyuki Ito, Jiro Okami, Keiju Aokage, Satoshi Shiono, Hiroshige Yoshioka, Tadashi Aoki, Yasuhiro Tsutani, Morihito Okada, Shun-ichi Watanabe
Japanese Journal of Clinical Oncology.2021; 51(1): 28.     CrossRef
Biomarkers and diagnostic tools for lung cancer
Sang Hoon Lee, Eun Hye Lee, Eun Young Kim, Yong Jun Choi, Yoon Jin Cha, Yoon Soo Chang
Journal of the Korean Medical Association.2021; 64(1): 66.     CrossRef
Treatment outcomes and safety of afatinib in advanced squamous cell lung cancer progressed after platinum‐based doublet chemotherapy and immunotherapy ( SPACE study)
Seung Hyeun Lee, Cheol‐Kyu Park, Sung Yong Lee, Chang‐Min Choi
Thoracic Cancer.2021; 12(8): 1264.     CrossRef
Recent Trends of Lung Cancer in Korea
Jae Guk Lee, Ho Cheol Kim, Chang-Min Choi
Tuberculosis and Respiratory Diseases.2021; 84(2): 89.     CrossRef
Efficacy and safety of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitor versus chemotherapy for advanced lung cancer
Pei-Pei Zhang, Juan Wang, Da-Zhi Ding, Li Zhang, Chun Cheng, Da-Ke Chen
Medicine.2021; 100(35): e27121.     CrossRef
Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
Chenlu Li, Jingjing Pan, Jing Luo, Xupeng Chen
BMC Pulmonary Medicine.2021;[Epub]     CrossRef
Overexpression of Reactive Oxygen Species Modulator 1 Predicts Unfavorable Clinical Outcome in EGFR-Mutant Lung Adenocarcinomas Treated With Targeted Therapy
Won Gun Kwack, Ji-Youn Sung, Seung Hyeun Lee
Frontiers in Oncology.2021;[Epub]     CrossRef
Acute myelomonocytic leukemia during pembrolizumab treatment for non-small cell lung cancer: A case report
Hong-Beum Kim, Sang-Gon Park, Ran Hong, Seong-Ho Kang, Yong Sub Na
World Journal of Clinical Cases.2020; 8(13): 2833.     CrossRef

Diagnostic and Predictive Values of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma

Il Ki Hong, Jeong Mi Lee, In Kyoung Hwang, Seung Sook Paik, Chanwoo Kim, Seung Hyeun Lee
Cancer Management and Research.2020; Volume 12: 6453.     CrossRef

High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy

Byung Woo Yoon, Boksoon Chang, Seung Hyeun Lee
OncoTargets and Therapy.2020; Volume 13: 8273.     CrossRef

Primary Resistance to Immune Checkpoint Blockade in an STK11/TP53/KRAS-Mutant Lung Adenocarcinoma with High PD-L1 Expression

Won Gun Kwack, So Youn Shin, Seung Hyeun Lee
OncoTargets and Therapy.2020; Volume 13: 8901.     CrossRef